v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity/(Deficit) - USD ($)
Number of shares
Share capital
Warrants Reserve
Reserves
Accumulated Deficit
Options Reserve
Total
Balance at Mar. 31, 2023   $ 5,934,141 $ 165,360 $ (6,299,946)   $ (200,445)
Balance (in Shares) at Mar. 31, 2023            
Issuance of shares to Psyence Group Inc    
Issuance of shares to Psyence Group Inc (in Shares) 1,338            
Issuance of shares to NCAC shareholders   37,336,416   37,336,416
Issuance of shares to NCAC shareholders (in Shares) 2,086            
Issuance of shares for debt settlement   718,500   718,500
Issuance of shares for debt settlement (in Shares) 40            
Issuance of shares to third party advisors   2,136,340   2,136,340
Issuance of shares to third party advisors (in Shares) 119            
Net profit (loss) for the year   (51,159,048)   (51,159,048)
Other comprehensive income (loss)   195,697   195,697
Balance at Mar. 31, 2024   46,125,397 361,057 (57,458,994)   (10,972,540)
Balance (in Shares) at Mar. 31, 2024 3,583            
Issuance of shares to third party advisors   241,379   241,379
Issuance of shares to third party advisors (in Shares) 94            
Issuance of shares for convertible note   4,617,286   4,617,286
Issuance of shares for convertible note (in Shares) 6,105            
Issuance of warrants   682,482   682,482
Issuance of shares for ELOC, net of issuance costs   6,410,395   6,410,395
Issuance of shares for ELOC, net of issuance costs (in Shares) 35,567            
Issuance of shares for warrant exchange   192,060   192,060
Issuance of shares for warrant exchange (in Shares) 177            
Issuance of shares for promissory notes   2,084,927   2,084,927
Issuance of shares for promissory notes (in Shares) 15,926            
Issuance of shares for Psyence Labs Ltd shares   722,033   722,033
Issuance of shares for Psyence Labs Ltd shares (in Shares) 5,695            
Issuance of units for PIPE financing, net of issuance costs   273,179 1,468,872   1,742,051
Issuance of units for PIPE financing, net of issuance costs (in Shares) 7,629            
Issuance of shares for warrant conversion   1,085,649 (1,085,649)  
Issuance of shares for warrant conversion (in Shares) 16,107            
Net profit (loss) for the year   1,011,790   1,011,790
Other comprehensive income (loss)   (9,859)   (9,859)
Balance at Mar. 31, 2025   61,752,305 1,065,705 351,198 (56,447,204) 6,722,004
Balance (in Shares) at Mar. 31, 2025 90,883            
Issuance of shares to third party advisors   60,000 60,000
Issuance of shares to third party advisors (in Shares) 2,439            
Issuance of shares for ELOC, net of issuance costs   13,964,060 13,964,060
Issuance of shares for ELOC, net of issuance costs (in Shares) 1,051,973            
Issuance of shares for investment in Associate   2,934,167 2,934,167
Issuance of shares for investment in Associate (in Shares) 1,146,159            
Share-based compensation   155,341 155,341
Issuance of shares on exercise of RSUs   37,451 (37,451)
Issuance of shares on exercise of RSUs (in Shares) 1,823            
Net profit (loss) for the year   (6,936,421) (6,936,421)
Other comprehensive income (loss)   44,979 44,979
Balance at Mar. 31, 2026   $ 78,747,983 $ 1,065,705 $ 396,177 $ (63,383,625) $ 117,890 $ 16,944,130
Balance (in Shares) at Mar. 31, 2026 2,293,277